Adjarai, Al-furqan .

HRN: 26-69-21  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2026
CEFUROXIME 750MG (VIAL)
06/23/2026
06/29/2026
IV
230mg
Q8
Acute Bacterial Infection
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines